ContentsSynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyDrug Reaction DataReferencesInformation for PatientsView all Images (134)
Nodular basal cell carcinoma
See also in: External and Internal Eye,Anogenital,Hair and Scalp
Print Captions OFF
Other Resources UpToDate PubMed

Nodular basal cell carcinoma

See also in: External and Internal Eye,Anogenital,Hair and Scalp
Print Patient Handout Images (134)
Contributors: Gaurav Singh MD, MPH, William M. Lin MD, Sarah Hocker DO, Belinda Tan MD, PhD, Susan Burgin MD
Other Resources UpToDate PubMed

Synopsis

Basal cell carcinoma (BCC) is the most common cancer in humans and the most common cancer of the skin. Two million Americans are diagnosed with BCC every year. It is a neoplasm of basal keratinocytes that is found more frequently in men than women. Rates of BCC have been increasing over the last several decades, particularly in young women. BCCs can be seen at almost any age. Nonetheless, the malignancy has greater incidence in older individuals, with a median age at diagnosis of 68 years.

There are many subtypes of BCC, including superficial, nodular, pigmented, and infiltrating. Nodular BCC is the most common subtype and accounts for half of all lesions. It is typically seen on the face, most commonly on the cheeks, nose, melolabial fold, forehead, and eyelids. Although BCCs typically arise in hair-bearing areas, they can rarely be seen in hairless genital mucosa for an unknown reason.

The greatest risk factor contributing to the development of BCCs is sun exposure, and people with light skin phototypes are at higher risk. Intermittent sun exposure is more associated with the development of BCCs than cumulative ultraviolet (UV) exposure. Other risk factors for BCCs include environmental exposure (ie, ionizing radiation, indoor tanning, chemicals such as arsenic, psoralen plus UVA, and coal tar), phenotype (freckling, red hair, fair skin that always burns and never tans), immunosuppression such as organ transplantation (which results in a 5-10 times higher risk of BCCs than the general population), and various genetic syndromes including xeroderma pigmentosum, oculocutaneous albinism, Muir-Torre syndrome, basal cell nevus syndrome (Gorlin syndrome), Rombo syndrome, and Bazex-Dupré-Christol syndrome. The gene most frequently altered in BCCs is the PTCH1 gene, followed by the TP53 gene.

Although BCCs are almost never fatal, local tissue destruction and disfiguration occur. The metastasis rate of BCCs is approximately 1 in 35 000. Metastasis is rare and typically occurs through perineural spread, lymph node metastasis, and then lung / bone metastasis.

Codes

ICD10CM:
C44.91 – Basal cell carcinoma of skin, unspecified

SNOMEDCT:
403911008 – Nodulo-ulcerative basal cell carcinoma

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

Drug Reaction Data

Below is a list of drugs with literature evidence indicating an adverse association with this diagnosis. The list is continually updated through ongoing research and new medication approvals. Click on Citations to sort by number of citations or click on Medication to sort the medications alphabetically.

Subscription Required

References

Subscription Required

Last Reviewed: 12/21/2018
Last Updated: 01/14/2019
Copyright © 2019 VisualDx®. All rights reserved.
Nodular basal cell carcinoma
See also in: External and Internal Eye,Anogenital,Hair and Scalp
Captions OFF Print 134 Images Filter Images
View all Images (134)
(with subscription)
 Reset
Nodular basal cell carcinoma : Telangiectasia, Sun-exposed distribution
Clinical image of Nodular basal cell carcinoma
A reddish plaque with telangiectasias and a raised, shiny, rolled border at the anterior hairline.
Copyright © 2019 VisualDx®. All rights reserved.